FindTrial
Sign In

Study on the Growth, Development, and Health of Offspring Born to Women with Polycystic Ovary Syndrome (PCOS) through Assisted Reproductive Technology (ART)

Study on the Growth, Development, and Health of Offspring Born to Women with Polycystic Ovary Syndrome (PCOS) through Assisted Reproductive Technology (ART)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100644
Enrollment
Unknown
Registered
2025-04-11
Start date
2022-11-03
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

PCOS group:NA
Control group:NA

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The PCOS group consists of patients diagnosed with PCOS according to the Rotterdam criteria and undergoing ART (Assisted Reproductive Technology) for conception, while the non-PCOS group includes patients undergoing ART due to tubal factors. 2. The maternal age at pregnancy ranges from 20 to 40 years old. 3. The subjects agreed to participate in follow-up and underwent follow-up at our hospital's reproductive center.

Exclusion criteria

Exclusion criteria: 1. Offspring from patients who used donor eggs or sperm. 2. Offspring with genetic diseases. 3. Underwent preimplantation genetic diagnosis (PGD) or preimplantation genetic screening (PGS) techniques.

Design outcomes

Primary

MeasureTime frame
Growth;Lipid;cogonition;thyroid function;blood glucose;—

Countries

China

Contacts

Public ContactZhu Yimin

Women's Hospital, School of Medicine, Zhejiang University

zhuyim@zju.edu.cn+86 136 0581 2866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026